Sack­lers call opi­oid-re­lat­ed fraud claims 'ut­ter­ly mer­it­less'

Months af­ter Pur­due Phar­ma’s bank­rupt­cy plan was foiled by the Supreme Court, its pre­vi­ous own­ers are brac­ing for a le­gal bat­tle with cred­i­tors.

The Sack­lers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.